Developer of non-invasive health technology designed to democratize access to early cancer risk assessment.
Eden has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in July 2024.
Eden's investors include Y Combinator, Khosla Ventures, Sierra Ventures, Alt Capital, Endeavor.
Eden is headquartered in Miguel Hidalgo, Mexico.
Developer of non-invasive health technology designed to democratize access to early cancer risk assessment.
Eden is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eden — Funding & Investors." VCBacked, July 11, 2024, https://www.vcbacked.co/company/eden-miguel-hidalgo. Accessed August 14, 2026.
VCBacked. (2024). Eden — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/eden-miguel-hidalgo
{{cite web |title=Eden — Funding & Investors |url=https://www.vcbacked.co/company/eden-miguel-hidalgo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated